Navigation Links
Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection
Date:11/10/2008


- Gene Signal International, a Biotech Company Registered in

Switzerland, Will Move its Headquarter to the EPFL, in Lausanne,

- Gene Signal is Addressing Various Issues Related to Neovascularisation,

- Gene Signal is Working on a Portfolio of Ophthalmologic Indications,

With One Now in Phase III Trials

- Gene Signal Will Present its Interim Results at the Annual Meeting of

the American Academy of Ophtalmologist in Atlanta, USA, the

Largest Scientific Convention in this Field

Gene Signal, a biotech company registered in Switzerland, is currently starting the Phase III study of GS-101, its most advanced therapeutic ophthalmic solution, for the prevention of corneal graft rejection.

Every year, over 40'000 corneal grafts are performed worldwide to cure or prevent blindness, thus making this procedure the most frequently performed transplant surgery. However, the 5 year failure rate for corneal grafts is currently around 35%. As many other graft procedures, donor grafts are always in limited supply. A failure is even more "wasteful" in this context of long waiting lines (6 months - 2 years).

One of the main reasons for graft failure is the immune response of the body. Normally, the cornea is avascular (i.e. deprived of blood vessels), protecting the donor cornea from being rejected. However, under certain circumstances, new blood vessel creation (neovascularization) occurs, inducing an immune response to the donor graft that can lead to immunological corneal graft rejection.

Currently, there is no therapy available. Gene Signal is working on new ways to prevent this syndrome. With its antisense oligonucleotide approach, it aims to block the pathways leading to the formation of blood vessels in the cornea. This approach uses short DNA fragments that specifically target and block the production of a protein that is required for the formation and growth of new blood vessels.

<
'/>"/>
SOURCE Gene Signal International SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Revealing the regulating mechanism behind signal transduction in the brain
2. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
3. Signalife Announces Anticipated Date of Transition to OTCBB
4. Signalife to Issue Breaking News Regarding Vianale & Vianale Tomorrow
5. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
6. AFL To Return to Oklahoma Due to Overwhelming Demand for Signalife Heart Screening
7. Signalife Board Approves Merger
8. Signalife Announces AFL Joins NIH Education Program
9. Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
10. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
11. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Md. , Dec. 24, 2014  United ... today that Medtronic, Inc. (NYSE: MDT ... the U.S. Food and Drug Administration (FDA) for ... implantable drug infusion system (including a newly developed ... (treprostinil) Injection delivered intravenously to patients with ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market ... (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, ... Forecasts to 2019” provides a detailed overview of ... trends, and strategies impacting the preparative and process ... of the revenue and share analysis. , ...
(Date:12/24/2014)... On Friday, December 19, 2014, ... Omnibus and Continuing Resolution Appropriations Act of 2015, ... condition eligible to receive funding through the Congressionally ... Department of Defense (DoD). The Hydrocephalus Association (HA), ... Hill, is celebrating this victory for the over ...
(Date:12/24/2014)... The report expects global cell isolation and expansion market ... a carefully analyzed data about the vital drivers, restraints, ... Full Copy of Report @ http://bit.ly/1yUxy0T , ... expansion will keep witnessing growth at an impressive CAGR ... driven by rapid technological advancements, government funding and investments, ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... the,Battelle National Biodefense Institute, LLC raised enough money ... Board,s Community Agency,School Services., "Having the required ... some,parents are challenged with given the cost," said ... for several years to provide all children in,Frederick ...
... --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) ... specializing in the manufacture,research, development, marketing ... it signed a one-year contract with ... to supply probiotics for,Square Pharmaceutical,s probiotics-based ...
... NovaRx Corporation announced today,that the company ... of,Lucanix(R) (belagenpumatucel-L) in the treatment of advanced ... enrolled in the study was treated by,Dr. ... the University,of California, San Diego School of ...
Cached Biology Technology:BNBI Employees Donate 1,000 Backpacks to Frederick County School Children 2China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base 2China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to ... This accomplishment enables HITLAB to conduct regulated smart ... highest principles for patient safety and research quality. ... healthcare access, quality, and delivery with innovative technology," ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2
... North telescope and W.M. Keck Observatory on Hawaii,s Mauna Kea, ... first-ever direct images identifying a multi-planet system around a normal ... make the initial discovery of two of the planets in ... 2007. Then, on Oct. 25, 2007, and in the summer ...
... microorganism discovered in the open ocean may force scientists to ... ocean ecosystems. A paper describing the new findings appears ... . A research team led by Jonathan Zehr, a ... the new microbe by analyzing its genetic material, even though ...
... life started remains a major challenge for science. At ... Science, conference in Sicily in October, scientists discussed two ... systems theory to the chemistry that preceded early life. ... evidence about what Earth was like when life evolved. ...
Cached Biology News:Planetary "first family" discovered by astronomers using Gemini and Keck Observatories 2Mysterious microbe plays important role in ocean ecology 2Mysterious microbe plays important role in ocean ecology 3Complex systems and Mars missions help understand how life began 2Complex systems and Mars missions help understand how life began 3
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
... and IHC Protocol Development ,Antibody Titer ... in Animal or Human Cells and ... and Tissues ,Peroxidase, Alkaline Phosphatase, Immunogold, ... Electron Microscopy ,Protein Localization in Transgenic ...
Biology Products: